“…These findings may help to enhance flap survival with the pharmacological strategy of an available drug administered by subcutaneous route, in addition to benefits such as affordable cost, easy administration, high therapeutic index, effective results, treatment feasibility, known mechanism of action when administered via oral and parenteral routes, bioavailability and protective effects on necrosis. Pentoxifylline suggests that it is dose-dependent, with a possible variability in the different effects based on the dose, schedule, route, and administration period 9,11,14,[28][29][30][31][32] .…”